Maybe a case of mistaken Identity :) Recent news
Post# of 148187
COVID-19 RECOVERY trial: HIV medicine found ineffective in treating hospitalised COVID-19 patients
Quote:
A combination of antiviral drugs used to treat HIV had no beneficial effect in patients hospitalised with COVID-19 in a large-scale randomised trial, British scientists said on Monday.
Scientists running the RECOVERY trial at the University of Oxford said that the results “convincingly rule out any meaningful mortality benefit of lopinavir-ritonavir in the hospitalised COVID-19 patients we studied.”
The scientists found no difference in mortality, length of hospital stay or the risk of being put on a ventilator, when they compared 1,596 patients given lopinavir-ritonavir with 3,376 patients in a control group.
Quote:
These preliminary results show that for patients hospitalised with COVID-19 and not on a ventilator, lopinavir-ritonavir is not an effective treatment,” Peter Horby, chief investigator for the trial, said.
So, lopinavir-ritonavir (Kaletra) is out of the competition. The WHO is running a trial as well, but with these results we are right a the front in contention.